Lassen Therapeutics
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
$85M Series B+ ·
Led by Frazier Life Sciences · Source: fundraisingfox.com
Total raised: $116M across 2 sourced rounds
All 2 rounds ↓Signals
Lassen Therapeutics | 607 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $85M | fundraisingfox.com | ||
| Series A | $31M | biospace.com |
Timeline
- Website created
Founders and team
DK
David King Co-Founder & CSOLinkedIn · source: lassentherapeutics.comMB
Mark Barrett FounderHT
H. Toni Jun VP, Preclinical DevelopmentMF
Maria Fardis Chief Executive OfficerRH
Robert Horlick Vice President, Molecular Cell Biology
Investors
AAlta Partners
BBiotechnology Value Fund
CCatalio
FFrazier Healthcare Partnerslead investor
FFrazier Life Scienceslead investor
LLongitude Capitallead investor
- LLongwood Capital Partners
LLongwood Fund
Companies like Lassen Therapeutics
VVedanta Biosciences$60M Series B+ · Aug 2026
SSudo Bio$37M Series A · Sep 2022AArtios Pharma$115M Series B+ · Nov 2025
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAtavistik Bio$40M Series B+ · Mar 2026
MMemo Therapeutics$22M Series B+ · May 2024
Other companies backed by Frazier Life Sciences
RRQ Bio$115M Series A · Jun 2026
IImmutrin$86.45M Series A · Mar 2026
AAngitia Bio$130M Series B+ · Feb 2026
AAirNexis Therapeutics$200M Series A · Jan 2026
AAspen Neuroscience$115M Series B+ · Nov 2025
TTubulis$360M Series B+ · Oct 2025
Frazier Life Sciences portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lassen-therapeutics (get a free API key).